Jennifer Elechko

Jennifer Elechko has extensive experience in research and development in various pharmaceutical and biotech companies. Jennifer specializes in cell line development, purification, and optimization of recovery processes for recombinant proteins to support early and late-stage research efforts and clinical trials. Jennifer also has experience in developing and optimizing cell-based assays, mechanism of action studies, and next-generation sequencing platforms. Their expertise includes mammalian cell culture, RNA isolation, quantitative RT-PCR analysis, and development and characterization of stable production cell lines.